Drug Repurposing in Dermatology: Molecular Biology and Omics Approach

F. Badria, Abdullah A. Elgazar
{"title":"Drug Repurposing in Dermatology: Molecular Biology and Omics Approach","authors":"F. Badria, Abdullah A. Elgazar","doi":"10.5772/intechopen.93344","DOIUrl":null,"url":null,"abstract":"The withdrawal of several blockbuster drugs due to severe adverse effects and the failure of several developed drugs in clinical trials raised questions about the efficacy of current approaches of drug discovery. Moreover, the limitation of resources and the long and costive process of drug discovery made a lot of pharmaceutical companies to employ drug repurposing strategies to get new insights about activities that were not considered during their initial discovery. The development of therapeutics for treatment of dermatological condition is not considered as priority although it affects the lifestyle of thousands of people around the world. Serendipity and observations have contributed significantly in this field but immerse efforts have been exerted to find systematic methods to identify new indications for drugs, especially with the unprecedented progress in molecular biology and omics. So, in this chapter, we will emphasize on different approaches used for drug repositioning and how it was applied to find new therapeutics for different dermatoses.","PeriodicalId":383661,"journal":{"name":"Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications","volume":"191 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5772/intechopen.93344","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

The withdrawal of several blockbuster drugs due to severe adverse effects and the failure of several developed drugs in clinical trials raised questions about the efficacy of current approaches of drug discovery. Moreover, the limitation of resources and the long and costive process of drug discovery made a lot of pharmaceutical companies to employ drug repurposing strategies to get new insights about activities that were not considered during their initial discovery. The development of therapeutics for treatment of dermatological condition is not considered as priority although it affects the lifestyle of thousands of people around the world. Serendipity and observations have contributed significantly in this field but immerse efforts have been exerted to find systematic methods to identify new indications for drugs, especially with the unprecedented progress in molecular biology and omics. So, in this chapter, we will emphasize on different approaches used for drug repositioning and how it was applied to find new therapeutics for different dermatoses.
皮肤病学中的药物再利用:分子生物学和组学方法
一些重磅药物由于严重的不良反应而退出,以及一些已开发药物在临床试验中的失败,使人们对当前药物发现方法的有效性提出了质疑。此外,资源的限制和药物发现的漫长而昂贵的过程使得许多制药公司采用药物再利用策略来获得在最初发现时没有考虑到的活动的新见解。尽管皮肤病影响着全世界成千上万人的生活方式,但它的治疗方法的发展并没有被视为优先事项。机机性和观察在这一领域做出了重大贡献,但人们一直在努力寻找系统的方法来确定药物的新适应症,特别是随着分子生物学和组学的前所未有的进展。因此,在本章中,我们将重点介绍用于药物重新定位的不同方法,以及如何将其应用于寻找针对不同皮肤病的新疗法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信